National Cheng Kung University Hospital

North Dist. 70403

0 studies enrolling now · 3 studies all time

What they study most

Advanced Malignancies, Non-small Cell Lung Cancer, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

Studies at this site

• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed
• A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed